Clinical study on the treatment of depression with venlafaxine under the guidance of pharmacogenomics testing
ObjectiveTo investigate the efficacy and safety of venlafaxine in the treatment of depression under the guidance of pharmacogenomics testing, and to provide references for individualized medication.MethodsA total of 66 patients who met the diagnostic criteria of International Classification of Disea...
Main Authors: | Xu Jinbing, Huang Wei, Guo Huagui, Huang Shiqing, Tang Chaohua, Liang Jiaquan, Li Xuesong |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Sichuan Mental Health
2021-06-01
|
Series: | Sichuan jingshen weisheng |
Subjects: | |
Online Access: | http://www.psychjm.net.cn/scjswszzen/ch/reader/view_abstract.aspx?file_no=202103010&flag=1 |
Similar Items
-
Comparative Analysis between Controlled Release Paroxetine and Extended-Release Venlafaxine for Treatment of Depression
by: Vijay Kaul, et al.
Published: (2022-06-01) -
Comparison of efficacy and tolerability of escitalopram and venlafaxine in treatment-naïve patients with unipolar nonpsychotic depression: Is there a need to revisit the prescription patterns?
by: Harneet Kaur, et al.
Published: (2019-01-01) -
Time course of effects of venlafaxine on migraine and generalized pruritus in a patient with depression
by: Yu Miyahara, et al.
Published: (2021-11-01) -
Reduction of methylphenidate induced anxiety, depression and cognition impairment by various doses of venlafaxine in rat
by: Majid Motaghinejad, et al.
Published: (2015-01-01) -
Administration of venlafaxine after chronic methadone detoxification blocks post-depression relapse in rats
by: Meysam Fadaei-Kenarsary, et al.
Published: (2017-08-01)